76 related articles for article (PubMed ID: 21604576)
21. Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure.
Sun LJ; Yu JW; Zhao YH; Kang P; Li SC
J Gastroenterol Hepatol; 2010 Mar; 25(3):583-90. PubMed ID: 19968744
[TBL] [Abstract][Full Text] [Related]
22. [The impact of HBeAg positivity/negativity and HBV DNA loads on the prognosis of chronic severe hepatitis B].
Sun QF; Lü Y; Xu DZ; Lan XY; Liu JY; Sun XJ
Zhonghua Gan Zang Bing Za Zhi; 2006 Jun; 14(6):410-3. PubMed ID: 16792862
[TBL] [Abstract][Full Text] [Related]
23. [A noninvasive model to predict histological liver cirrhosis in patients with chronic hepatitis B].
Tu XL; Xiao YQ; Chen F
Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):28-32. PubMed ID: 19203448
[TBL] [Abstract][Full Text] [Related]
24. The burden and recent epidemiological changes of the main chronic liver diseases in a Greek referral tertiary centre.
Giannousis IP; Papatheodoridis GV; Deutsch MJ; Manolakopoulos SG; Manesis EK; Koskinas JS; Archimandritis AJ
Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):172-9. PubMed ID: 19738477
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C.
Sakai T; Shiraki K; Inoue H; Okano H; Deguchi M; Sugimoto K; Ohmori S; Murata K; Nakano T
Int J Mol Med; 2002 Aug; 10(2):201-4. PubMed ID: 12119559
[TBL] [Abstract][Full Text] [Related]
26. [The clinical outcomes and influencing factors of chronic hepatitis B virus infection].
Ren H
Zhonghua Gan Zang Bing Za Zhi; 2010 Jun; 18(6):401-2. PubMed ID: 20587305
[No Abstract] [Full Text] [Related]
27. Discriminant function for prognostic indexes and probability of death in chronic severe hepatitis B.
Ke WM; Ye YN; Huang S
J Gastroenterol; 2003; 38(9):861-4. PubMed ID: 14564632
[TBL] [Abstract][Full Text] [Related]
28. Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study.
Liu J; Yang HI; Lee MH; Lu SN; Jen CL; Wang LY; You SL; Iloeje UH; Chen CJ;
Gastroenterology; 2010 Aug; 139(2):474-82. PubMed ID: 20434450
[TBL] [Abstract][Full Text] [Related]
29. Poor durability of lamivudine effectiveness despite stringent cessation criteria: a prospective clinical study in hepatitis B e antigen-negative chronic hepatitis B patients.
Liu F; Wang L; Li XY; Liu YD; Wang JB; Zhang ZH; Wang YZ
J Gastroenterol Hepatol; 2011 Mar; 26(3):456-60. PubMed ID: 21332542
[TBL] [Abstract][Full Text] [Related]
30. [Chronic hepatitis B and C in HIV-infected patients].
Opravil M; Hunziker R; Lüthy R; Grob PJ
Dtsch Med Wochenschr; 1998 Jun; 123(24):753-60. PubMed ID: 9672477
[TBL] [Abstract][Full Text] [Related]
31. Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model.
Sun QF; Ding JG; Xu DZ; Chen YP; Hong L; Ye ZY; Zheng MH; Fu RQ; Wu JG; Du QW; Chen W; Wang XF; Sheng JF
J Viral Hepat; 2009 Jul; 16(7):464-70. PubMed ID: 19413694
[TBL] [Abstract][Full Text] [Related]
32. Predictive factors for early HBeAg seroconversion in acute exacerbation of patients with HBeAg-positive chronic hepatitis B.
Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
Gastroenterology; 2009 Feb; 136(2):505-12. PubMed ID: 19101558
[TBL] [Abstract][Full Text] [Related]
33. Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Yang HI; Sherman M; Su J; Chen PJ; Liaw YF; Iloeje UH; Chen CJ
J Clin Oncol; 2010 May; 28(14):2437-44. PubMed ID: 20368541
[TBL] [Abstract][Full Text] [Related]
34. [An analysis of the relationship between HBV DNA and HBeAg expression and mortality in 799 severe hepatitis patients].
Wang RB; Zhou GQ; Jiang YY; Sun FX; Wu YZ; Sun JY; Meng PP; Niu SM
Zhonghua Gan Zang Bing Za Zhi; 2006 Sep; 14(9):655-7. PubMed ID: 16995977
[TBL] [Abstract][Full Text] [Related]
35. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
Huang YH; Wu JC; Chen CH; Chang TT; Lee PC; Chau GY; Lui WY; Chang FY; Lee SD
Liver Int; 2005 Apr; 25(2):236-41. PubMed ID: 15780044
[TBL] [Abstract][Full Text] [Related]
36. Long-term outcome of chronic hepatitis B based on histological grade and stage.
Park BK; Park YN; Ahn SH; Lee KS; Chon CY; Moon YM; Park C; Han KH
J Gastroenterol Hepatol; 2007 Mar; 22(3):383-8. PubMed ID: 17295771
[TBL] [Abstract][Full Text] [Related]
37. Comparative serum proteomic analysis of patients with acute-on-chronic liver failure: alpha-1-acid glycoprotein maybe a candidate marker for prognosis of hepatitis B virus infection.
Ren F; Chen Y; Wang Y; Yan Y; Zhao J; Ding M; Zhang J; Jiang Y; Zhai Y; Duan Z
J Viral Hepat; 2010 Nov; 17(11):816-24. PubMed ID: 20002297
[TBL] [Abstract][Full Text] [Related]
38. Determination of serum hepatitis B virus DNA in chronic HBsAg carriers: clinical significance and correlation with serological markers.
Yalçin K; Değertekin H; Alp MN; Tekeş S; Satici O; Budak T
Turk J Gastroenterol; 2003 Sep; 14(3):157-63. PubMed ID: 14655057
[TBL] [Abstract][Full Text] [Related]
39. [An analysis of the pathohistology of liver tissues, clinical features and prognostic factors of chronic hepatitis B virus carriers].
Wu CH; Si CW; Tian GS; Yu YY; Xu XY; Wang TL
Zhonghua Gan Zang Bing Za Zhi; 2007 Aug; 15(8):577-81. PubMed ID: 17711625
[TBL] [Abstract][Full Text] [Related]
40. Early mortality in Taiwanese lamivudine-treated patients with chronic hepatitis B-related decompensation: evaluation of the model for end-stage liver disease and index scoring systems as prognostic predictors.
Dai CY; Chuang WL; Hou NJ; Lee LP; Hsieh MY; Lin ZY; Chen SC; Huang JF; Hsieh MY; Wang LY; Tsai JF; Wen-Yu ; Yu ML
Clin Ther; 2006 Dec; 28(12):2081-92. PubMed ID: 17296464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
